Anura Contactless Health Monitoring Platform
NuraLogix
Contact Person:
Michael Keefe, VP of Global Sales
michaelkeefe@nuralogix.ai
NuraLogix has been pioneering contactless patient vital monitoring since 2015, and this year they’ve released their most powerful tool yet. The Anura platform is the only video-based contactless health monitoring solution that can measure vital signs and provide health risk assessments by analyzing facial blood flow patterns. Unlike wearable devices that use sensors to detect a user’s blood flow, Anura can gather 30 health parameters from a simple video selfie.
Using proprietary Transdermal Optical Imaging (TOI) and sophisticated AI analysis, the Anura platform extrapolates health information from the pattern of facial blood flow, allowing NuraLogix to become the first company able to use this technology to accurately measure blood pressure without a cuff. The groundbreaking platform has expanding capabilities, with the most recent added ability to carry out metabolic and blood biomarker health risk assessments to its existing ability to assess mental health and cardiovascular disease risk assessments, including 10-year predictions of risk of death from heart attack or stroke. The expansion also included the ability to assess HbA1c and monitor fasting glucose and assess risk of type 2 diabetes, hypertension, and hypertriglyceridemia.
Anura allows healthcare monitoring to take place on any video-enabled device, which expands access to health monitoring as well as expanding the industries that the health tech sector can reach. Using ubiquitous devices, Anura has the potential to accelerate the adoption of solutions for the early detection of chronic diseases and expand health equity and access to underserved populations while dramatically decreasing costs of care.
Anura tech is backed by 10 global peer-reviewed research publications, and three in progress covering topics of hypertension, multi-year cardiovascular risk, diabetes, and fatty liver disease.
